• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE XPEDITION; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE XPEDITION; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1074300-23
Medical Device Problem Codes Difficult to Remove (1528); Material Separation (1562); Improper or Incorrect Procedure or Method (2017); Difficult to Advance (2920); Material Deformation (2976)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 11/28/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Exemption number e2019001.(b)(4).The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported that the procedure was performed to treat a non-tortuous, moderately calcified, 80% stenosed mid left anterior descending coronary artery.A 3x23mm xience xpedition stent delivery system (sds) was being advanced when resistance with a non-abbott guiding catheter was noted.The sds was being removed when resistance with the same guiding catheter was noted, and some force was applied.The shaft of the sds separated and was removed along with the guiding catheter.The unimplanted stent was noted to have flared stent struts.Another 3x23mm xience xpedition stent was used to successfully complete the procedure.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
A visual inspection was performed on the returned device.The reported material separation and material deformation were confirmed.The reported difficult to advance and difficult to remove could not be tested due to the condition of the returned device.It should be noted that the xience xpedition, everolimus eluting coronary stent system (eecss), instructions for use (ifu), states: if unusual resistance is felt before the stent exits the guiding catheter, do not force passage.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents.The investigation determined the reported difficulties appear to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION
Common Device Name
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9488829
Report Number2024168-2019-14681
Device Sequence Number2079672
Product Code NIQ
UDI-Device Identifier08717648162350
UDI-Public08717648162350
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/17/2022
Device Model Number1074300-23
Device Catalogue Number1074300-23
Device Lot Number9061341
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/28/2019
Initial Date Received by Manufacturer 11/29/2019
Supplement Date Received by Manufacturer02/19/2020
Initial Report FDA Received Date12/18/2019
Supplement Report FDA Received Date03/11/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
6F EBU 3.75 GUIDE CATHETER
-
-